Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C
Public ClinicalTrials.gov record NCT00305383. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Analysis of Hepatitis C Viral Kinetics and Viramidine Pharmacokinetics Utilizing Two Treatment Regimens in Therapy-Naive Patients With Chronic Hepatitis C
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to examine the rapid virologic response (RVR) at combination therapy (CT) Week 4 between groups receiving a standard combination peginterferon alfa-2b/viramidine dosing regimen versus a cohort that receives 4 weeks of viramidine monotherapy prior to the start of peginterferon alfa-2b/viramidine combination therapy.
Study identification
- NCT ID
- NCT00305383
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2005
- Primary completion
- Not listed
- Completion
- Apr 30, 2007
- Last update posted
- Jun 21, 2012
2005 – 2007
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Southern California -- Keck School of Medicine | Los Angeles | California | 90033 | — |
| San Mateo Medical Center | San Mateo | California | 94403 | — |
| Bach and Godofsky | Bradenton | Florida | 34205 | — |
| University of Miami -- Center for Liver Diseases | Miami | Florida | 33136 | — |
| Digestive Healthcare of Georgia | Atlanta | Georgia | 30309 | — |
| Maryland Digestive Disease Research | Laurel | Maryland | 20707 | — |
| Atlantic Gastroenterology Associates | Egg Harbor | New Jersey | 08234 | — |
| Liver Center of Long Island | Plainview | New York | 11803 | — |
| Thomas Jefferson University -- Gastroenterology and Hepatology | Philadelphia | Pennsylvania | 19107 | — |
| Mountain West Gastroenterology -- Research Office | Salt Lake City | Utah | 84121 | — |
| Metropolitan Research -- Georgetown Medical Center | Fairfax | Virginia | 22031 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00305383, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 21, 2012 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00305383 live on ClinicalTrials.gov.